Camurus
在场
Camurus 是一家在股票代码 CAMX (SE) 下上市的公司。
高管
查看带有其 18 名主要高管的组织结构图
Camurus 搜索最多的简介
- Fredrik Tiberg, Chief Executive Officer and Director
- Hege Hellstrom, Board Member
- Stefan Persson, Board Member
高管在Camurus变化
- Kerstin Valinder Strinnholm, Director, 已经离开公司 (新闻发布的2024四月4号).
- Ole Vahlgren, Director, 已经离开公司 (新闻发布的2024四月4号).
- Behshad Sheldon 曾任 Director, 将于 20244月1 升职为 President of USA (新闻发布的2024二月14号).
创建提醒
跟踪 Camurus 的高管变动
生物技术
Camurus 拥有 2,276 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Histogen has filed for bankruptcy protection (公布2024四月19号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
生物技术 行业的其他推荐联系人
消息
Camurus 的最新新闻稿
- Camurus Annual Report for 2023 - Camurus
- Notice of annual general meeting 2024 in Camurus (publ) - Camurus
- Camurus announces FDA acceptance of NDA submission for Oclaiz™ for treatment of acromegaly - Camurus
- Camurus appoints Behshad Sheldon as President of Camurus Inc. - Camurus
- Camurus’ Full Year Report 2023 - Camurus
- Completed enrollment in the POSITANO study of CAM2029 in patients with polycystic liver disease - Camurus
- Change in number of shares and votes in Camurus - Camurus
- Camurus intends to carry out a directed share issue of approximately 2 million shares and provides preliminary financial information for FY 2023 - Camurus
- Camurus has carried out a directed share issue of 2,000,000 shares at a subscription price of SEK 545 per share, raising gross proceeds of SEK 1,090 million - Camurus
- Change in number of shares and votes in Camurus - Camurus
- View more press releases Close
关于 Camurus 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Fredrik Tiberg 
